Funds holding “BRIDGEBIO PHARMA INC”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
24 positions across 22 funds, 5 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| GCV Gabelli Convertible & Income Securities Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAJ1 | DBT | 2.08% | $2M | Jun 30, 2026 | full (121 positions) |
| BCV Bancroft Fund U.S. Equity | BRIDGEBIO PHARMA INC | 10806XAJ1 | DBT | 1.98% | $3.8M | Jun 30, 2026 | full (88 positions) |
| ECF Ellsworth Growth & Income Fund U.S. Equity | BRIDGEBIO PHARMA INC | 10806XAJ1 | DBT | 1.80% | $4.2M | Jun 30, 2026 | full (99 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | BRIDGEBIO PHARMA INC | 10806X102 | EC | 1.66% | $3.8M | Jun 30, 2026 | full (195 positions) |
| CCD Calamos Dynamic Convertible & Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAK8 | DBT | 1.13% | $10.6M | Jul 31, 2026 | full (596 positions) |
| CHI Calamos Convertible Opportunities & Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAK8 | DBT | 0.93% | $12.7M | Jul 31, 2026 | full (601 positions) |
| CHY Calamos Convertible & High Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAK8 | DBT | 0.91% | $13.2M | Jul 31, 2026 | full (601 positions) |
| NCZ Virtus Convertible & Income Fund II Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.82% | $3.8M | Jul 31, 2026 | full (211 positions) |
| NCV Virtus Convertible & Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.79% | $4.8M | Jul 31, 2026 | full (210 positions) |
| ACV Virtus Diversified Income & Convertible Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.75% | $2.8M | Jul 31, 2026 | full (281 positions) |
| NIE Virtus Equity & Convertible Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.48% | $3.7M | Jul 31, 2026 | full (164 positions) |
| RVT Royce Small-Cap Trust U.S. Equity | Bridgebio Pharma Inc | 10806X102 | EC | 0.33% | $8.7M | Jun 30, 2026 | full (427 positions) |
| AVK Advent Convertible & Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAJ1 | DBT | 0.27% | $2M | Jul 31, 2026 | full (466 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Bridgebio Pharma Inc | 10806X102 | EC | 0.25% | $2.7M | Jun 30, 2026 | full (170 positions) |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund U.S. Equity | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.25% | $3.7M | Jul 31, 2026 | full (170 positions) |
| AVK Advent Convertible & Income Fund Convertible Securities | BRIDGEBIO PHARMA INC | 10806XAK8 | DBT | 0.24% | $1.8M | Jul 31, 2026 | full (466 positions) |
| GGZ Gabelli Global Small & Mid Cap Value Trust Global Equity | BRIDGEBIO PHARMA INC | 10806X102 | EC | 0.23% | $372K | Jun 30, 2026 | full (321 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | BRIDGEBIO PHARMA INC | 10806XAK8 | DBT | 0.23% | $11M | Jul 31, 2026 | full (820 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Bridgebio Pharma Inc | 10806X102 | EC | 0.10% | $585K | Jun 30, 2026 | full (152 positions) |
| VGI Virtus Global Multi-Sector Income Fund Multi-Asset | BRIDGEBIO PHARMA INC | 10806XAD4 | DBT | 0.01% | $9.7K | May 29, 2026 | full (758 positions) |
| VGI Virtus Global Multi-Sector Income Fund Multi-Asset | BRIDGEBIO PHARMA INC | 10806XAB8 | DBT | 0.01% | $6.5K | May 29, 2026 | full (758 positions) |
| GAB Gabelli Equity Trust U.S. Equity | BRIDGEBIO PHARMA INC | 10806X102 | EC | 0.00% | $55.9K | Jun 30, 2026 | full (709 positions) |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund Covered Call / Option Income | Bridgebio Pharma Inc | 10806X102 | EC | 0.00% | $53K | Jun 30, 2026 | full (556 positions) |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust U.S. Equity | Bridgebio Pharma Inc | 10806X102 | EC | -0.16% | $-407K | Jul 31, 2026 | full (761 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.